文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

比较经皮经肝胆管引流术和内镜逆行胰胆管造影术联合支架置入术治疗不可切除胆管癌胆道梗阻的疗效。

Comparing the efficacy of initial percutaneous transhepatic biliary drainage and endoscopic retrograde cholangiopancreatography with stenting for relief of biliary obstruction in unresectable cholangiocarcinoma.

机构信息

Division of Surgical Oncology, Department of Surgery, University of Louisville, 550 S. Jackson Street, Louisville, KY, 40202, USA.

Department of Radiology, Norton Hospital, Louisville, KY, USA.

出版信息

Surg Endosc. 2020 Mar;34(3):1186-1190. doi: 10.1007/s00464-019-06871-2. Epub 2019 May 28.


DOI:10.1007/s00464-019-06871-2
PMID:31139984
Abstract

BACKGROUND: In patients with cholangiocarcinoma (CC), management of biliary obstruction commonly involves either up-front percutaneous transhepatic biliary drainage (PTBD) or initial endoscopic retrograde cholangiopancreatography (ERCP) with stent placement. The objective of the study was to compare the efficacy and of initial ERCP with stent placement with efficacy of initial PTBD in management of biliary obstruction in CC. METHODS: A single-center database of patients with unresectable CC treated between 2006 and 2017 was queried for patients with biliary obstruction who underwent either PTBD or ERCP. Groups were compared with respect to patient, tumor, procedure, and outcome variables. RESULTS: Of 87 patients with unresectable CC and biliary obstruction, 69 (79%) underwent initial ERCP while 18 (21%) underwent initial PTBD. Groups did not differ significantly with respect to age, gender, or tumor location. Initial procedure success did not differ between the groups (94% ERCP vs 89% PTBD, p = 0.339). Total number of procedures did not differ significantly between the two groups (ERCP median = 2 vs. PTC median = 2.5, p = 0.83). 21% of patients required ERCP after PTBD compared to 25% of patients requiring PTBD after ERCP (p = 1.00). Procedure success rate (97% ERCP vs. 93% PTBD, p = 0.27) and rates of cholangitis (22% ERCP vs. 17% PTBD, p = 0.58) were similar between the groups. Number of hospitalizations since initial intervention did not differ significantly between the two groups (ERCP median = 1 vs. PTC median = 3.5, p = 0.052). CONCLUSIONS: In patients with CC and biliary obstruction, initial ERCP with stent placement and initial PTBD both represent safe and effective methods of biliary decompression. Initial ERCP and stenting should be considered for relief of biliary obstruction in such patients in centers with advanced endoscopic capabilities.

摘要

背景:在胆管癌(CC)患者中,胆道梗阻的管理通常涉及经皮经肝胆道引流(PTBD)或初始内镜逆行胰胆管造影(ERCP)联合支架置入。本研究的目的是比较初始 ERCP 联合支架置入与初始 PTBD 在 CC 胆道梗阻管理中的疗效。

方法:检索了 2006 年至 2017 年间在一家中心治疗的不可切除 CC 患者的单中心数据库,以确定接受 PTBD 或 ERCP 的胆道梗阻患者。比较两组患者、肿瘤、手术和结果变量。

结果:在 87 例不可切除 CC 合并胆道梗阻的患者中,69 例(79%)接受了初始 ERCP,18 例(21%)接受了初始 PTBD。两组患者在年龄、性别或肿瘤位置方面无显著差异。初始手术成功率在两组间无显著差异(94%ERCP 与 89%PTBD,p=0.339)。两组之间的总手术次数无显著差异(ERCP 中位数=2 次与 PTC 中位数=2.5 次,p=0.83)。与需要 ERCP 的患者相比,需要 PTBD 的患者中有 21%在接受 PTBD 后需要再次 ERCP,而需要 ERCP 的患者中有 25%在接受 ERCP 后需要再次 PTBD(p=1.00)。两组间的手术成功率(97%ERCP 与 93%PTBD,p=0.27)和胆管炎发生率(22%ERCP 与 17%PTBD,p=0.58)相似。两组患者自初始干预以来的住院次数无显著差异(ERCP 中位数=1 次与 PTC 中位数=3.5 次,p=0.052)。

结论:在 CC 合并胆道梗阻的患者中,初始 ERCP 联合支架置入和初始 PTBD 均是安全有效的胆道减压方法。在具有先进内镜能力的中心,应考虑在这些患者中采用初始 ERCP 和支架置入来缓解胆道梗阻。

相似文献

[1]
Comparing the efficacy of initial percutaneous transhepatic biliary drainage and endoscopic retrograde cholangiopancreatography with stenting for relief of biliary obstruction in unresectable cholangiocarcinoma.

Surg Endosc. 2020-3

[2]
Combination of endoscopic retrograde cholangiopancreatography and endoscopic ultrasonography-guided biliary drainage in malignant hilar biliary obstruction.

Dig Endosc. 2019-4

[3]
A comparative evaluation of EUS-guided biliary drainage and percutaneous drainage in patients with distal malignant biliary obstruction and failed ERCP.

Dig Dis Sci. 2014-8-1

[4]
EUS-guided biliary drainage with electrocautery-enhanced lumen-apposing metal stent placement should replace PTBD after ERCP failure in patients with distal tumoral biliary obstruction: a large real-life study.

Surg Endosc. 2022-5

[5]
Selective MRCP and CT-targeted drainage of malignant hilar biliary obstruction with self-expanding metallic stents.

Gastrointest Endosc. 2003-7

[6]
Endoscopic ultrasound-guided biliary drainage versus percutaneous transhepatic biliary drainage: predictors of successful outcome in patients who fail endoscopic retrograde cholangiopancreatography.

Surg Endosc. 2016-12

[7]
Percutaneous transhepatic self-expanding metal stents for palliation of malignant biliary obstruction.

S Afr J Surg. 2012-7-11

[8]
Expandable metal stents for malignant hilar biliary obstruction.

Gastrointest Endosc Clin N Am. 2011-7

[9]
Endoscopic ultrasound-guided biliary drainage of hilar biliary obstruction.

J Hepatobiliary Pancreat Sci. 2015-9

[10]
Stent implantation through rendezvous technique of PTBD and ERCP: the treatment of obstructive jaundice.

J Dig Dis. 2007-11

引用本文的文献

[1]
Case Report: Sequential PTCD and biliary seed stent combined with targeted-immunotherapy for advanced pancreatic cancer with malignant obstructive jaundice: a multidisciplinary approach.

Front Oncol. 2025-8-19

[2]
Comparative Efficacy of Magnetic Resonance Cholangiopancreatography vs. Percutaneous Transhepatic Cholangiography With Percutaneous Transhepatic Biliary Drainage Stenting in Evaluating Obstructive Jaundice: A Prospective Study in South India.

Cureus. 2024-7-24

[3]
False-negative factors of percutaneous transluminal clamp biopsy for suspected malignant biliary stricture: 194 cases analyzed from a single center.

Insights Imaging. 2024-4-12

[4]
Feasibility of Magnetic Resonance Cholangiopancreatography in Dogs-A Post-Mortem Study.

Animals (Basel). 2023-8-4

[5]
The Role of Lumen Apposing Metal Stents in the Palliation of Distal Malignant Biliary Distal Obstruction.

Cancers (Basel). 2023-5-12

[6]
Impact of endobiliary radiofrequency ablation on survival of patients with unresectable cholangiocarcinoma: a narrative review.

Front Oncol. 2023-5-30

[7]
Comparison of Efficacy and Safety between Endoscopic Retrograde Cholangiopancreatography and Percutaneous Transhepatic Cholangial Drainage for the Treatment of Malignant Obstructive Jaundice: A Systematic Review and Meta-Analysis.

Digestion. 2023

[8]
Impact of regular additional endobiliary radiofrequency ablation on survival of patients with advanced extrahepatic cholangiocarcinoma under systemic chemotherapy.

Sci Rep. 2022-1-19

[9]
The Clinical Management of Cholangiocarcinoma in the United States and Europe: A Comprehensive and Evidence-Based Comparison of Guidelines.

Ann Surg Oncol. 2021-5

本文引用的文献

[1]
Oncologic effects of preoperative biliary drainage in resectable hilar cholangiocarcinoma: Percutaneous biliary drainage has no adverse effects on survival.

J Surg Oncol. 2018-5

[2]
Endoscopic versus Percutaneous Biliary Drainage in Palliation of Advanced Malignant Hilar Obstruction: A Meta-Analysis and Systematic Review.

Can J Gastroenterol Hepatol. 2016-8-25

[3]
Forty-Year Trends in Cholangiocarcinoma Incidence in the U.S.: Intrahepatic Disease on the Rise.

Oncologist. 2016-5

[4]
Preoperative biliary drainage in perihilar cholangiocarcinoma: identifying patients who require percutaneous drainage after failed endoscopic drainage.

Endoscopy. 2015-12

[5]
Percutaneous Preoperative Biliary Drainage for Resectable Perihilar Cholangiocarcinoma: No Association with Survival and No Increase in Seeding Metastases.

Ann Surg Oncol. 2015-12

[6]
Perioperative Management of Hilar Cholangiocarcinoma.

J Gastrointest Surg. 2015-10

[7]
Palliation: Hilar cholangiocarcinoma.

World J Hepatol. 2014-8-27

[8]
Complications of endoscopic retrograde cholangiopancreatography: how to avoid and manage them.

Gastroenterol Hepatol (N Y). 2013-8

[9]
Oncological benefit of preoperative endoscopic biliary drainage in patients with hilar cholangiocarcinoma.

J Hepatobiliary Pancreat Sci. 2014-8

[10]
Chemotherapy for cholangiocarcinoma: An update.

World J Gastrointest Oncol. 2013-7-15

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索